6-iodoclorgyline
(125)-idodoclorgyline may have potential as a radiopharmaceutical for MAO-A studies in the brain with SPECT; structure given in first source
Also Known As:
(125I)-6-iodoclorgyline; N-(3-(2,4-dichloro-6-iodophenoxy)propyl)-N-methyl-2-propynylamine; iodoclorgyline
Networked: 0
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results